Future MDMA Treatment Following FDA's Rejection
Podcast: Cato PodcastPublished On: Fri Sep 13 2024
Description: The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment. Hosted on Acast. See acast.com/privacy for more information.
The note was deleted
The note was saved
Your message was sent